CIK 0001377121
- Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980505495
- Phone
- +1 510-474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 4 Open-market sale President and CEO sold 48,273 shares at an average $84.18 ($4,063,743)
- 4 Open-market sale Chief Financial Officer sold 46,203 shares at an average $83.13 ($3,841,037)
- 4 Open-market sale Chief Medical Officer sold 23,151 shares at an average $82.30 ($1,905,305)
- 4 Open-market sale Chief Medical Officer sold 9,514 shares at $82.48 ($784,715)
- 4 Open-market sale President and CEO sold 34,438 shares at $82.48 ($2,840,446)
- 4 Open-market sale Chief Financial Officer sold 8,588 shares at $82.48 ($708,338)
- 4 Exercise or conversion Director acquired 14,299 shares (option exercise)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award President and CEO acquired 95,400 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,600 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 25,600 shares (grant or award)
- 4 Gift President and CEO gave 440 shares (gift)
- 4 Open-market sale Chief Medical Officer sold 2,712 shares at $84.77 ($229,896)
- 4 Planned sale Director sold 12,000 shares at an average $81.62 ($979,480)
- 4 Planned sale Director sold 4,000 shares at $64.25 ($257,000)
- 4 Gift President and CEO gave 620 shares (gift)
Page 2 of 15 · 293 filings